PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced its participation in Guggenheim’s SMID Cap Biotech ...

President Donald Trump rescinded an order freezing an array of federal grants, loans and financial assistance, a dramatic ...

Spain will raise the minimum wage by 4.4% in 2025, according to Labor Minister Yolanda Diaz.Most Read from BloombergTrump's ...

President Donald Trump assailed the Federal Reserve’s approach to bank regulation and accused Chair Jay Powell of fumbling ...

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

SAN FRANCISCO and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Guggenheim ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team will ...

Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today ...

Guggenheim Securities SMID Cap Biotech Conference, New York Fireside Chat Wednesday, February 5, 2025, at 1:30 pm ET A live webcast and replay, when available, will be available under "Events and ...

The Guggenheim Strategic Opportunities Fund has boasted impressive returns, beating out the S&P 500 since my first recommendation. Learn more on GOF CEF here.

Unmissable on the banks of the Nervión River, the audacious and lyrical Guggenheim Museum Bilbao is as much a work of art as the collections it contains within its curved walls.